KS

Kavita Suraj Zanvar

Director Director DIN 02437570
DIN 02437570 First appointment May 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2009
Shareholding value •••• Premium profile

About Kavita Suraj Zanvar

Data last updated:

Kavita Suraj Zanvar was a Director at Dr. Smiths Biotech Private Limited (2015–2019) and Director at Cian Healthcare Limited (2009–2016). The companies operate in Pharma.

DIN 02437570
Primary Designation Director
Industry Pharma
First Appointment 20 May 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr. Smiths Biotech Private Limited U24246PN2015PTC154818
Director24 Apr 20152015₹22.70 Cr (FY 2023)Under Cirp
Cian Healthcare Limited L24233PN2003PLC017563
Director20 May 20092003₹62.14 Cr (FY 2024)Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr. Smiths Biotech Private Limited
Cian Healthcare Limited
Premium access

Shareholding and investment profile for Kavita Suraj Zanvar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavita Suraj Zanvar

Kavita Suraj Zanvar was first appointed on 20 May 2009 as Director at Cian Healthcare Limited. The most recent appointment on record is 24 Apr 2015 at Dr. Smiths Biotech Private Limited.

Kavita Suraj Zanvar held 2 earlier board appointments: Dr. Smiths Biotech Private Limited (Director, 24 Apr 2015 to 03 Jun 2019); Cian Healthcare Limited (Director, 20 May 2009 to 22 May 2016).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available